Triple synchronous primary neoplasms in the gastrointestinal tract by 김남규 et al.
CorrespondenceTriple synchronous primary neoplasms in the gastrointestinal tractFozan Mohammed Sauri1, Eman Adnan Zakarneh1, Mohammed Yousef Alessa1,2, Ahmad Hammad Sakr1,3,
Yeon Seung Chung4, Ho Seung Kim1, Nam kyu Kim1
1Department of Surgery, Colorectal Division, Yonsei University College of Medicine, Seoul, 120-752, South Korea;
2Department of General Surgery, King Faisal University, Alahsa 31982, Saudi Arabia;
3Colorectal Surgery Unit, Department of General Surgery, Mansoura Faculty of Medicine, Mansoura University Hospital, Mansoura 35511, Egypt;
4Department of Pathology, Yonsei University College of Medicine, Seoul 120-752, South Korea.To the Editor: Most of the multiple primary malignancies
are metachronous or involve more than one system, we
instead describe a case with synchronous triple cancers
involving one organ system.
This studywas approved by the Institutional Review Board
of Severance hospital, Yonsei University (IRB No. 4-2019-
0889). A 61-year old man who had no chronic illness,
underwent abdominal computerized tomography (CT)
scan due to vague abdominal complains and was found to
have descending colon wall thickening [Figure 1A], colon
cancer (cT3N+) was suspected. He is not smoker or alcohol
drunker, and has no family history of malignancies. His
chest CT scan results showed esophageal wall thickening
[Figure 1B]. Upper gastrointestinal tract (GIT) endoscopy
results showed mid esophageal mass [Figure 1C] and
gastric mucosal lesion [Figure 1D] diagnosed by biopsy
squamous cell carcinoma and adenocarcinoma respectively.
Likewise, colonoscopy results showed a mass in the
descending colon [Figure 1E], which was histopathologi-
cally confirmed to be adenocarcinoma. The patient
underwent upper GIT endoscopic ultrasound and results
showed an esophageal mass [Figure 1F] with an enlarged
lymph node [Figure 1G], indicating clinical-stage cT4N1,
while the gastric lesion [Figure 1H] was staged as cT1aN0.
Endoscopic mucosal resection (EMR) was performed for
stomach cancer. Histopathology findings showed well-
differentiated adenocarcinoma without lymphovascular or
perineural invasion and with negative resection margins
[Figure 1I]. The patient underwent robotic esophagectomy
and cervical esophagogastrostomy (upfront surgery).
Histopathology results [Figure 1J] showed squamous cell
carcinoma (pT2N2), thus, adjuvant chemotherapy was
initiated (5-fluorouracil and cisplatin). LaparoscopicAccess this article online




1233left hemicolectomy was done. Histopathology results
[Figure 1K] showed adenocarcinoma (pT1N0), the genetic
study showed kirsten rat sarcoma viral oncogene (KRAS)
gene and neuroblastoma ras viral oncogene homolog
(NRAS) gene are wild types and Microsatellite stable.
The difference between the initial clinical stage (cT3N+)
and the pathological stage (pT1N0) for the colon cancer is
probably a response to the 5-fluorouracil based adjuvant
chemotherapy post oesophageal cancer. One year after
surgery, the patient had no complications (both early and
late), with no recurrence on last follow up and has a good
quality of life.
In our case, the treatment of the stomach cancer by EMR
started first and it was successful and sowewere able to use
it for the reconstruction of GIT continuity.
Although international guidelines for the management of
clinical stages II and III mid-esophageal cancer indicate
neoadjuvant chemoradiotherapy followed by surgery,[1] in
our patient we performed upfront surgery followed by
adjuvant chemotherapy when indicated dependent on final
histopathology to avoid delay in the treatment of other
primary cancers. Matsuda et al[2] reported no significant
difference in overall five years survival between the
neoadjuvant chemotherapy followed by surgery and
upfront surgery (P = 0.167). Chen et al[3] also found no
survival difference between neoadjuvant chemoradiation
followed by surgery and the upfront surgery with patho-
logical stage-based adjuvant chemo-radiation (P= 0.147).
In conclusion, we report our case to highlight that
healthcare professionals need special strategies for the
management of multiple primary malignancies to provide
the best oncological outcomes.Correspondence to: Prof. Nam Kyu Kim, Division of Colorectal Surgery, Department
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Figure 1: (A–B) Computerized tomography of colon cancer and esophageal cancer, respectively (the arrows). (C–E) Endoscopic visualization of esophageal cancer, gastric cancer, and colon
cancer, respectively. (F–H) Endoscopic ultrasound visualizations of esophageal cancer, mediastinal lymph node, and stomach cancer, respectively (the arrows). (I–K). Histopathology results
of stomach cancer, esophageal cancer, and colon cancer respectively (Hematoxylin-eosin stain, original magnification, 100).
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